EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease

Aleksandra Korta, Julia Kula, Krzysztof Gomułka iD

International Journal of Molecular Sciences · 15.06.2023 · 24 (12) · 10172

DOI: 10.3390/ijms241210172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.06.2023. Verfasst von Aleksandra Korta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Group of Adult Allergology, Wroclaw Medical University, 50-369 Wroclaw, Poland. Hauptthemen laut MEDLINE: Interleukin-23, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-23 (IL-23) is a proinflammatory cytokine produced mainly by macrophages and antigen-presenting cells (APCs) after antigenic stimulation. IL-23 plays a significant role as a mediator of tissue damage. Indeed, the irregularities in IL-23 and its receptor signaling have been implicated in inflammatory bowel disease. IL-23 interacts with both the innate and adaptive immune systems, and IL-23/Th17 appears to be involved in the development of chronic intestinal inflammation. The IL-23/Th17 axis may be a critical driver of this chronic inflammation. This review summarizes the main aspects of IL-23’s biological function, cytokines that control cytokine production, effectors of the IL-23 response, and the molecular mechanisms associated with IBD pathogenesis. Although IL-23 modulates and impacts the development, course, and recurrence of the inflammatory response, the etiology and pathophysiology of IBD are not completely understood, but mechanism research shows huge potential for clinical applications as therapeutic targets in IBD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-23Inflammatory Bowel DiseasesHumansCytokinesInflammationMacrophagesIntestinal Mucosa

Stichwörter der Autor:innen

12/23 cytokinesCrohn’s diseaseeffectorsinflammatory bowel diseaseinterleukin-23pathogenesistreatmentulcerative colitis

Substanzen

Interleukin-23Cytokines

Autor:innen und Institutionen

  • Student Scientific Group of Adult Allergology, Wroclaw Medical University, 50-369 Wroclaw, Poland.
  • Clinical Department of Internal Medicine, Pneumology and Allergology, Wroclaw Medical University, 50-369 Wroclaw, Poland.

ORCID-Profile: Krzysztof Gomułka

Zitieren

APA

Korta, A., Kula, J., & Gomułka, K. (2023). The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. International Journal of Molecular Sciences, 24(12), 10172. https://doi.org/10.3390/ijms241210172

Vancouver

Korta A, Kula J, Gomułka K. The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2023;24(12):10172. doi:10.3390/ijms241210172

BibTeX
@article{Korta2023,
  author = {Korta, Aleksandra and Kula, Julia and Gomułka, Krzysztof},
  title = {The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {12},
  pages = {10172},
  doi = {10.3390/ijms241210172}
}
Kostenlos starten →